Mesoblast Limited (MSB) Wins FDA OK For New Ryoncil Potency Assay
Mesoblast received FDA approval to implement its T-cell Proliferation Inhibition BioAssay (TIBA) for release and stability monitoring of commercial Ryoncil batches, alongside existing potency assays under its Biologics License.Material DetailsContext by AI AnalystThis is a mid-cycle regulatory-manu…